<DOC>
	<DOCNO>NCT02946944</DOCNO>
	<brief_summary>Pilot randomize study sidlenafil efficacy combination oral anticoagulant treatment patient intermediate-high risk pulmonary embolism</brief_summary>
	<brief_title>Sidlenafil Combination With Oral Anticoagulants Patients With Intermediate-high Risk Pulmonary Embolism</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>pulmonary embolism confirm CT scan contrast , localization thrombusa least one main proximal lobar pulmonary artery . Rightleft ventricular ratio ( RV / LV ) â‰¥1 derive apical fourchamber view Who give write informed consent participate research Age &lt; 18 &gt; 80 year Symptoms pulmonary embolism &gt; 14 day Inadequate echocardiographic image quality apical fourchamber projection , limit measurement RV / LV ratio A significant risk bleed The administration thrombolytic drug within previous 4 day Active bleed Known coagulopathy Thrombocytopenia &lt; 100,10^9 / l Previous use vitamin K antagonists INR &gt; 2.5 admission History intracranial spinal surgery trauma intracranial / spinal bleed Intracranial neoplasm Arteriovenous malformation aneurysms GIH &lt; 3 month Cataract Surgery Obstetrical manipulation Cardiopulmonary resuscitation need . Other invasive procedure &lt; 10 day Allergy , hypersensitivity , thrombocytopenia heparin tissue plasminogen activator Allergy iodine contrast A wellknown rightleft cardiac shunt , example , large patent foramen ovale , atrial septal defect ; large ( &gt; 10 mm ) , blood clot right atrium/right ventricle Systolic blood pressure &lt; 90 mm Hg least 15 minute , fall systolic blood pressure le 40 mm Hg least 15 min. , evidence organ hypoperfusion ( cold extremity low diuresis &lt; 30 mL / h , confusion ) , need administration catecholamine maintain adequate perfusion organ systolic blood pressure &gt; 90 mm Hg Severe hypertension ( systolic &gt; 180 mm Hg diastolic &gt; 105 mm Hg. ) . Pregnancy , lactation , delivery &lt; 30 day Participation study ( drug device ) Life expectancy &lt; 90 day Refusal participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pulmonary Embolism</keyword>
	<keyword>sildenafil</keyword>
	<keyword>oral anticoagulation therapy</keyword>
</DOC>